All News

Regardless of the pattern of physical activity, it may reduce risk across a spectrum of cardiovascular diseases, say study authors. So, just do it!

The challenge posed by a complaint of back pain is not that the origin is unknowable but rather the remarkable heterogeneity in this condition, says the president-elect of the American Academy of Physical Medicine & Rehabilitation.

Your daily dose of clinical news you may have missed.

Disparities in emergency routing persisted despite women being acutely sicker than men and living the same distance from a comprehensive stroke center, in a Houston, Tx study.

Guidelines on primary ASCVD prevention from the USPSTF and the AHA/ACC/Multisociety differ on why and when to initiate a statin. Try the 5-question quiz.

Young adults who smoke tobacco cigarettes or vape showed early signals of atherosclerosis compared with nonsmokers in a small, cross-sectional study.

Your daily dose of clinical news you may have missed.

Total perioperative dosage of opioids was higher for abdominal vs laparoscopic hysterectomy, but procedure route was not associated with risk for long-term opioid use.

Nirsevimab won unanimous support from the FDA AMDAC on the vaccine's positive benefit/risk profile to prevent RSV in newborns and infants in their first RSV season.

Findings from meta-analysis showed preoperative high-intensity interval training was associated with improvements in exercise capacity and a reduction in postoperative complications.

Primary care clinicians will need to be particularly alert for signs of long COVID in older patients as some signs and symptoms may be easily attributed to the aging process.

Your daily dose of clinical news you may have missed.

Factors positively associated with a timely first OAC Rx among the 41.3% who received one included male sex, certain comorbidities, other current medications, and obesity.

FDA approval of the monoclonal antibody against RSV follows the unanimous vote from the agency's Antimicrobial Drugs Advisory Committee.

Preventive cardiologist Elizabeth Klodas, MD, reviews the essential elements of a plan of eating shown clinically to reduce hyperlipidemia.

Howard Fillit, MD, cofounder/chief scientific officer of the Alzheimer Drug Discovery Foundation, says lecenumab's approval opens the door for future drug development.

For the 25-30 million uninsured adults in the US, the program, which will end in December 2024, will ensure access to protection from the virus for another year.

AspyreRx™, prescribed in 90-day increments, resulted in a mean HbA1c reduction of 1.3% at 180 days in 1 out of 2 phase 3 trial participants. A Q4 launch is anticipated.